WO2003002085A1 - Use of purified, water-soluble xylans extracted from palmaria - Google Patents

Use of purified, water-soluble xylans extracted from palmaria Download PDF

Info

Publication number
WO2003002085A1
WO2003002085A1 PCT/FR2002/002048 FR0202048W WO03002085A1 WO 2003002085 A1 WO2003002085 A1 WO 2003002085A1 FR 0202048 W FR0202048 W FR 0202048W WO 03002085 A1 WO03002085 A1 WO 03002085A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
xylans
palmaria
skin
hair
Prior art date
Application number
PCT/FR2002/002048
Other languages
French (fr)
Inventor
Claude Dal Farra
Nouha Domloge
Dominique Peyronel
Original Assignee
Societe D'extraction Des Principes Actifs (Vincience Sa)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe D'extraction Des Principes Actifs (Vincience Sa) filed Critical Societe D'extraction Des Principes Actifs (Vincience Sa)
Publication of WO2003002085A1 publication Critical patent/WO2003002085A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9717Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Definitions

  • the present invention relates to the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended for:
  • the present invention also relates to cosmetic methods for treating the manifestations of aging, hydrating and regenerating the skin and the hair.
  • the primary object of the invention is the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to increase hydration and regeneration of the skin and hair.
  • purified water-soluble xylans extracts of Palmaria
  • water-soluble xylans extracts of the alga Palmaria palmata also called Dulce or Dulse.
  • These xylans are presented in purified form, which means a purity greater than 90%.
  • Another subject of the invention is the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to treat curatively and / or preventively the cutaneous manifestations of aging (of physiological and solar origin).
  • the term cutaneous manifestation of aging must be understood by a modification of the skin due to chronobiological or photo-induced aging such as, for example, fine lines and wrinkles, thin skin, slowing down of cell regeneration.
  • Another subject of the invention is the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to nourish the skin and the hair. Also, the invention is characterized in that the purified water-soluble xylans, extracts of Palmaria are used in the form of powder or in solution in a solvent suitable for cosmetics.
  • the purified water-soluble xylans extracted from Palmaria are used in an amount representing from 0.0001% to 5% of the total weight of the composition, and preferably in an amount representing from 0.002% to 1% of the total weight of the composition.
  • compositions according to the present invention will be in a galleic form suitable for administration by the topical skin route, and cover all cosmetic or dermatological forms.
  • These compositions must therefore contain a cosmetically acceptable medium, that is to say compatible with the skin, hair or hair.
  • These compositions may in particular be in the form of creams, oil-in-water emulsions, water-in-oil or multiple emulsions, solutions, suspensions, or even powders, suitable for application to the skin, the lips and / or the hair. .
  • compositions can be more or less fluid and have the appearance of a cream, a lotion, a milk, a serum, an ointment, a gel, a paste or a foam. They can also be in solid form, such as a stick or be applied to the skin in the form of an aerosol. They can be used as a care product and / or as a make-up product for the skin.
  • compositions comprise, in a known manner, the adjuvants necessary for their formulation, such as solvents, thickeners, diluents, antioxidants, dyes, filters, pigments, fillers, preservatives, perfumes, odor absorbers.
  • these adjuvants as well as their proportions, will be chosen so as not to harm the properties sought in the invention.
  • These adjuvants can, for example, correspond to 0.01 to 20% of the total weight of the composition.
  • the fatty phase may represent from 5 to 80% by weight and preferably from 5 to 50% by weight relative to the total weight of the composition.
  • the emulsifiers and coemulsifiers used in the composition will be chosen from those conventionally used in the field under consideration. For example, they can be used in a proportion ranging from 0.3 to 30% by weight, relative to the total weight of the composition.
  • the invention also relates to a cosmetic process for the treatment of the manifestations of aging, consisting in applying, to the skin or the hair, the composition as defined above.
  • the invention finally relates to a cosmetic process for hydration and cell regeneration, consisting in applying, to the skin or the hair, the composition as defined above.
  • Palmaria palmata (Dulce or Dulse) are crushed and then hydrolyzed in 1 liter of demineralized water with an enzymatic cocktail, at a temperature varying from 30 to
  • the released xylans are then separated from proteins and other Palmaria compounds.
  • Example 2 Effects of the Xylans of Example 1 on the Synthesis of Fibronectin
  • Fibroblasts were cultured and then cultured in the 8-well labteks. At 50% confluence, concentrations of 0.5% to 3% of the xylan extract of Example 1 were applied to the cells for 24 hours. Then the cells were fixed with methanol. Immunolabelling was then carried out with a revelation of peroxidase (DAB), to demonstrate the synthesis of fibronectin.
  • DAB peroxidase
  • Example 3 Effects of the xylans of Example 1 on cell regeneration
  • Fibroblasts were cultured and then cultured in the 8-well labteks. At 50% confluence, concentrations of 0.5% to 3% of the xylan extract of Example 1 were applied to the cells for 24 hours. Then the cells were fixed with methanol. Immunolabelling with the antibody Ki67 was then carried out with revelation with peroxidase (DAB), in order to demonstrate cell regeneration.
  • DAB peroxidase
  • Palmaria xylans stimulate cell regeneration.
  • Skin samples of approximately 1 cm 2 obtained after surgery are cultured in the 6-well dishes.
  • the active ingredient is applied at concentrations of 1 to 3% delicately using a brush on the epidermis.
  • the skin samples are fixed in 9% salt formalin for 10 hours and then included in the paraffin in an automated manner. Sections of 2 to 3 ⁇ m are then made and then stained with hematoxylin-eosin-saffron. Observation of the sections under the microscope reveals that in the presence of the xylans extracted from Palmaria of Example 1, the stratum corneum is clearly better hydrated. So Palmaria xylans hydrate the skin.
  • compositions were obtained by simple mixing of the various components.
  • the quantities indicated are given as a percentage by weight.
  • Oily phase a Montanov 68 (Cetearyl Alcohol and Cetearyl Glucoside) 5.00% Jojoba Oil 5.00% Vaseline Oil 5.00% Isopropyl Palmitate 7.00%
  • Aqueous phase a Glycerin 5.00% a Allantoin 0.10% a Xylans from Example 1 5.00% a Sepigel 305 (Polyacrylamide and Cl 3-14 Isoparaffin and Laureth-7) 0.30% a Preservative 0.50% a Perfume 0.50% a Water qs 100 %
  • a Carbopol Ultrez l0 (2% sol.) 25.00% a Triethanolamine 0.50% a Xylans of example 1 1.0% a Preservative 0.20% a EDTA (sequestering) 0.10% a Perfume 0.50% a Water qs 100%

Abstract

The invention relates to the use of an effective quantity of purified, water-soluble xylans extracted from Palmaria in a composition or for the preparation of one such composition. Said xylans or said composition is designed to: increase hydration and regeneration of the skin and hair; treat the cutaneous signs of ageing (of physiological and solar origin) in a curative and/or preventive manner; and nourish the skin and hair. The invention also relates to cosmetic methods used to treat signs of ageing and to hydrate and regenerate the skin and hair.

Description

UTILISATION DE XYLANES HYDROSOLUBLES PURIFIES, EXTRALTS DE USE OF PURIFIED WATER-SOLUBLE XYLANES, EXTRALTS OF
PALMARIAPALMARIA
La présente invention concerne l'utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés à :The present invention relates to the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended for:
- augmenter rhydratation et la régénération de la peau et des cheveux,- increase hydration and regeneration of the skin and hair,
- traiter de manière curative et/ou préventive les manifestations cutanées du vieillissement (d'origine physiologique et solaire),- treat curatively and / or preventively the skin manifestations of aging (of physiological and solar origin),
- nourrir la peau et les cheveux.- nourish the skin and hair.
La présente invention concerne aussi des procédés cosmétiques pour traiter les manifestations du vieillissement, hydrater et régénérer la peau et les cheveux.The present invention also relates to cosmetic methods for treating the manifestations of aging, hydrating and regenerating the skin and the hair.
Depuis la crise de la vache folle, il y a de cela une décennie, l'industrie cosmétique s'est détournée des principes actifs bovins, mais aussi de plus en plus de tous les principes actifs animaux. Ces derniers représentaient pourtant, il n'y a pas si longtemps, la source principale d'actifs cosmétiques du fait de l'évidente similitude entre de nombreuses molécules de la peau et les cellules animales. Les extraits végétaux, déjà très utilisés par le passé, restent une voie de recherche importante, mais de nouvelles études ont vu le jour ces dix dernières années. Aussi, les produits issus des biotechnologies et les produits marins ont été abondamment étudiés. Parmi ces derniers, on peut distinguer les extraits de poissons comme, par exemple, les élastines et collagènes marins, et les extraits d'algues marines comme, par exemple, les alginates, les carraghénates, les mucopolysaccharides et les oligo-éléments. De façon générale, ces extraits marins sont peu purifiés.Since the mad cow crisis, a decade ago, the cosmetic industry has turned away from bovine active ingredients, but also more and more from all animal active ingredients. However, not long ago, they were the main source of cosmetic active ingredients due to the obvious similarity between many skin molecules and animal cells. Plant extracts, already widely used in the past, remain an important avenue of research, but new studies have emerged over the past ten years. Also, products from biotechnology and marine products have been extensively studied. Among the latter, a distinction can be made between fish extracts such as, for example, marine elastins and collagens, and extracts from marine algae such as, for example, alginates, carrageenans, mucopolysaccharides and trace elements. In general, these marine extracts are little purified.
Une des tendances de la cosmétique moderne est de développer des extraits purifiés, c'est- à-dire pour lesquels la presque totalité de l'actif est définie. Peu de principes actifs extraits de macro-algues entrent dans cette catégorie.One of the trends in modern cosmetics is to develop purified extracts, that is to say for which almost all of the active ingredients are defined. Few active ingredients extracted from macroalgae fall into this category.
On constate donc que subsiste le besoin d'un produit nouveau, purifié, extrait d'algues marines. Or, la demanderesse a trouvé, de façon surprenante et inattendue, qu'une quantité efficace de xylanes hydrosolubles purifiés, extraits de l'algue Palmaria, a une action sur la peau.We therefore see that there remains a need for a new, purified product, extracted from seaweed. However, the Applicant has found, surprisingly and unexpectedly, that an effective amount of purified water-soluble xylans, extracted from the alga Palmaria, has an action on the skin.
A la connaissance de la demanderesse, il n'a jamais été décrit dans l'art antérieur l'utilisation de xylanes hydrosolubles purifiés, extraits de Palmaria, en cosmétique.To the knowledge of the applicant, the use of purified water-soluble xylans, extracts of Palmaria, has never been described in the prior art in cosmetics.
Ainsi, l'invention a pour objet premier l'utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés, à augmenter l'hydratation et la régénération de la peau et des cheveux.Thus, the primary object of the invention is the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to increase hydration and regeneration of the skin and hair.
Par la suite, le terme « xylanes hydrosolubles purifiés, extraits de Palmaria, » doit s'entendre par des xylanes solubles dans l'eau, extraits de l'algue Palmaria palmata encore appelée Dulce ou Dulse. Ces xylanes sont présentés sous forme purifiée, ce qui s'entend par une pureté supérieure à 90 %.Thereafter, the term “purified water-soluble xylans, extracts of Palmaria,” must be understood by water-soluble xylans, extracts of the alga Palmaria palmata also called Dulce or Dulse. These xylans are presented in purified form, which means a purity greater than 90%.
L'invention a pour autre objet l'utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés à traiter de manière curative et/ou préventive les manifestations cutanées du vieillissement (d'origine physiologique et solaire).Another subject of the invention is the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to treat curatively and / or preventively the cutaneous manifestations of aging (of physiological and solar origin).
Par la suite, le terme manifestation cutanée du vieillissement doit s'entendre par une modification de la peau due au vieillissement chronobiologique ou photo-induit comme, par exemple, les rides et ridules, la peau mince, le ralentissement de la régénération cellulaire.Subsequently, the term cutaneous manifestation of aging must be understood by a modification of the skin due to chronobiological or photo-induced aging such as, for example, fine lines and wrinkles, thin skin, slowing down of cell regeneration.
L'invention a pour autre objet l'utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés à nourrir la peau et les cheveux. Aussi, l'invention est caractérisée en ce que les xylanes hydrosolubles purifiés, extraits de Palmaria sont utilisés sous forme de poudre ou en solution dans un solvant adapté à la cosmétique.Another subject of the invention is the use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to nourish the skin and the hair. Also, the invention is characterized in that the purified water-soluble xylans, extracts of Palmaria are used in the form of powder or in solution in a solvent suitable for cosmetics.
Pour donner un ordre de grandeur, dans les compositions cosmétiques ou dermatologiques de la présente invention, les xylanes hydrosolubles purifiés, extraits de Palmaria sont utilisés en une quantité représentant de 0,0001 % à 5 % du poids total de la composition, et préférentiellement en une quantité représentant de 0,002 % à 1 % du poids total de la composition.To give an order of magnitude, in the cosmetic or dermatological compositions of the present invention, the purified water-soluble xylans extracted from Palmaria are used in an amount representing from 0.0001% to 5% of the total weight of the composition, and preferably in an amount representing from 0.002% to 1% of the total weight of the composition.
Préférentiellement, les compositions, selon la présente invention, se présenteront sous une forme galé ique adaptée à Fadministration par voie topique cutanée, et couvrent toutes les formes cosmétiques ou dermatologiques. Ces compositions doivent donc contenir un milieu cosmétiquement acceptable, c'est-à-dire compatible avec la peau, les poils ou les cheveux. Ces compositions pourront notamment se présenter sous forme de crèmes, émulsions huile-dans-eau, eau-dans-huile ou émulsions multiples, solutions, suspensions, ou encore poudres, adaptées à une application sur la peau, les lèvres et/ou les cheveux.Preferably, the compositions according to the present invention will be in a galleic form suitable for administration by the topical skin route, and cover all cosmetic or dermatological forms. These compositions must therefore contain a cosmetically acceptable medium, that is to say compatible with the skin, hair or hair. These compositions may in particular be in the form of creams, oil-in-water emulsions, water-in-oil or multiple emulsions, solutions, suspensions, or even powders, suitable for application to the skin, the lips and / or the hair. .
Ces compositions peuvent être plus ou moins fluides et avoir l'aspect d'une crème, d'une lotion, d'un lait, d'un sérum, d'une pommade, d'un gel, d'une pâte ou d'une mousse. Elles peuvent aussi se présenter sous forme solide, comme un stick ou être appliquées sur la peau sous forme d'aérosol. Elles peuvent être utilisées comme produit de soin et/ou comme produit de maquillage de la peau.These compositions can be more or less fluid and have the appearance of a cream, a lotion, a milk, a serum, an ointment, a gel, a paste or a foam. They can also be in solid form, such as a stick or be applied to the skin in the form of an aerosol. They can be used as a care product and / or as a make-up product for the skin.
Ces compositions comprennent, de façon connue, les adjuvants nécessaires à leur formulation, tels que solvants, épaississants, diluants, anti-oxydants, colorants, filtres, pigments, charges, conservateurs, parfums, absorbeurs d'odeur. Dans tous les cas, ces adjuvants, ainsi que leurs proportions, seront choisis de manière à ne pas nuire aux propriétés recherchées dans l'invention. Ces adjuvants peuvent, par exemple, correspondre à 0,01 à 20 % du poids total de la composition.These compositions comprise, in a known manner, the adjuvants necessary for their formulation, such as solvents, thickeners, diluents, antioxidants, dyes, filters, pigments, fillers, preservatives, perfumes, odor absorbers. In all cases, these adjuvants, as well as their proportions, will be chosen so as not to harm the properties sought in the invention. These adjuvants can, for example, correspond to 0.01 to 20% of the total weight of the composition.
Lorsque la composition de l'invention est une émulsion, la phase grasse peut représenter de 5 à 80 % en poids et de préférence de 5 à 50 % en poids par rapport au poids total de la composition. Les émulsionnants et coémulsionnants utilisés dans la composition seront choisis parmi ceux classiquement utilisés dans le domaine considéré. Par exemple, ils peuvent être utilisés en une proportion allant de 0,3 à 30 % en poids, par rapport au poids total de la composition.When the composition of the invention is an emulsion, the fatty phase may represent from 5 to 80% by weight and preferably from 5 to 50% by weight relative to the total weight of the composition. The emulsifiers and coemulsifiers used in the composition will be chosen from those conventionally used in the field under consideration. For example, they can be used in a proportion ranging from 0.3 to 30% by weight, relative to the total weight of the composition.
Bien entendu, l'homme de métier veillera à choisir les éventuels composés complémentaires, actifs ou non-actifs, et/ou leurs quantités, de telle sorte que les propriétés avantageuses du mélange ne soient pas, ou sensiblement pas, altérées par l'adjonction envisagée.Of course, the person skilled in the art will take care to choose any additional compounds, active or non-active, and / or their quantities, so that the advantageous properties of the mixture are not, or not substantially, altered by the addition considered.
L'invention concerne aussi un procédé cosmétique pour le traitement des manifestations du vieillissement, consistant à appliquer, sur la peau ou les cheveux, la composition telle que définie précédemment.The invention also relates to a cosmetic process for the treatment of the manifestations of aging, consisting in applying, to the skin or the hair, the composition as defined above.
L'invention concerne enfin un procédé cosmétique pour l'hydratation et la régénération cellulaire, consistant à appliquer, sur la peau ou les cheveux, la composition telle que définie précédemment.The invention finally relates to a cosmetic process for hydration and cell regeneration, consisting in applying, to the skin or the hair, the composition as defined above.
D'autres avantages et caractéristiques de l'invention apparaîtront mieux à la lecture des exemples donnés à titre ilmstratif et non limitatif.Other advantages and characteristics of the invention will appear better on reading the examples given by way of illustration and without limitation.
Exemple 1 - Préparation de xylanes hydrosolubles purifiés, extraits de PalmariaExample 1 Preparation of Purified Water Soluble Xylans Extracted from Palmaria
100 grammes de Palmaria palmata (Dulce ou Dulse) sont broyés puis hydrolyses dans 1 litre d'eau déminéralisée par un cocktail enzymatique, à une température évoluant de 30 à100 grams of Palmaria palmata (Dulce or Dulse) are crushed and then hydrolyzed in 1 liter of demineralized water with an enzymatic cocktail, at a temperature varying from 30 to
60 °C au cours des 6 heures de la réaction, et à un pH d'abord acide puis neutre.60 ° C during the 6 hours of the reaction, and at a pH initially acid then neutral.
Les xylanes libérés sont ensuite séparés des protéines et autres composés de la Palmaria.The released xylans are then separated from proteins and other Palmaria compounds.
Puis le produit est désodorisé et décoloré avec un mélange de charbons actifs avant d'être stérilisé par chauffage. La solution ainsi obtenue contient environ 20 grammes par litre de xylanes hydrosolubles et une pureté en xylanes supérieure à 90 %. Exemple 2 - Effets des xylanes de l'exemple 1 sur la synthèse de fibronectineThen the product is deodorized and discolored with a mixture of active carbon before being sterilized by heating. The solution thus obtained contains approximately 20 grams per liter of water-soluble xylans and a purity of xylans greater than 90%. Example 2 Effects of the Xylans of Example 1 on the Synthesis of Fibronectin
Des fibroblastes ont été cultivés puis mis en culture dans les labteks de 8 puits. A 50 % de confluence, des concentrations de 0,5 % à 3 % de l'extrait de xylanes de l'exemple 1 ont été appliquées sur les cellules pendant 24 heures. Puis les cellules ont été fixées au méthanol. Un immuno-marquage a ensuite été réalisé avec une révélation à la péroxydase (DAB), pour mettre en évidence la synthèse de fibronectine.Fibroblasts were cultured and then cultured in the 8-well labteks. At 50% confluence, concentrations of 0.5% to 3% of the xylan extract of Example 1 were applied to the cells for 24 hours. Then the cells were fixed with methanol. Immunolabelling was then carried out with a revelation of peroxidase (DAB), to demonstrate the synthesis of fibronectin.
Une analyse d'image permettant la quantification a finalement été réalisée à l'aide du logiciel Samba Technologie. Dès une concentration de 0,5 % de l'extrait de l'exemple 1, une augmentation nette et statistiquement très significative (méthode de Student) a été observée. Donc, les xylanes de Palmaria stimulent la synthèse de fibronectine.An image analysis allowing quantification was finally carried out using Samba Technology software. From a concentration of 0.5% of the extract of Example 1, a clear and statistically very significant increase (Student's method) was observed. Therefore, Palmaria xylans stimulate the synthesis of fibronectin.
Exemple 3 — Effets des xylanes de l'exemple 1 sur la régénération cellulaireExample 3 - Effects of the xylans of Example 1 on cell regeneration
Des fibroblastes ont été cultivés puis mis en culture dans les labteks de 8 puits. A 50 % de confluence, des concentrations de 0,5 % à 3 % de l'extrait de xylanes de l'exemple 1 ont été appliquées sur les cellules pendant 24 heures. Puis les cellules ont été fixées au méthanol. Un immuno-marquage avec l'anticorps Ki67 a ensuite été réalisé avec une révélation à la péroxydase (DAB), pour mettre en évidence la régénération cellulaire.Fibroblasts were cultured and then cultured in the 8-well labteks. At 50% confluence, concentrations of 0.5% to 3% of the xylan extract of Example 1 were applied to the cells for 24 hours. Then the cells were fixed with methanol. Immunolabelling with the antibody Ki67 was then carried out with revelation with peroxidase (DAB), in order to demonstrate cell regeneration.
Une analyse d'image permettant la quantification a finalement été réalisée à l'aide du logiciel Samba Technologie.An image analysis allowing quantification was finally carried out using Samba Technology software.
Dès une concentration de 0,5 % de l'extrait de l'exemple 1, une augmentation nette et statistiquement très significative (méthode de Student) a été observée.From a concentration of 0.5% of the extract of Example 1, a clear and statistically very significant increase (Student's method) was observed.
Donc, les xylanes de Palmaria stimulent la régénération cellulaire.Therefore, Palmaria xylans stimulate cell regeneration.
Exemple 4 - Effets des xylanes de l'exemple 1 sur Fhydratation cutanéeEXAMPLE 4 Effects of the Xylans of Example 1 on Skin Hydration
Des échantillons de peau d'environ 1 cm2 obtenus après chirurgie sont mis en culture dans les boîtes de 6 puits. L'actif est appliqué à des concentrations de 1 à 3 % délicatement à l'aide d'un pinceau sur l'épiderme. Après 24 heures, les échantillons de peau sont fixés au formol salé à 9 % pendant 10 heures puis inclus dans la paraffine de façon automatisée. Des coupes de 2 à 3 μm sont ensuite réalisées puis colorées à i'hématoxyline-éosine- safran. L'observation des coupes au microscope révèle qu'en présence des xylanes extraits de Palmaria de l'exemple 1, la couche cornée est nettement mieux hydratée. Donc, les xylanes de Palmaria hydratent la peau.Skin samples of approximately 1 cm 2 obtained after surgery are cultured in the 6-well dishes. The active ingredient is applied at concentrations of 1 to 3% delicately using a brush on the epidermis. After 24 hours, the skin samples are fixed in 9% salt formalin for 10 hours and then included in the paraffin in an automated manner. Sections of 2 to 3 μm are then made and then stained with hematoxylin-eosin-saffron. Observation of the sections under the microscope reveals that in the presence of the xylans extracted from Palmaria of Example 1, the stratum corneum is clearly better hydrated. So Palmaria xylans hydrate the skin.
Exemple 5 - Préparation de compositionsExample 5 Preparation of Compositions
Ces compositions ont été obtenues par simple mélange des différents composants. Les quantités indiquées sont données en pourcentage de poids.These compositions were obtained by simple mixing of the various components. The quantities indicated are given as a percentage by weight.
1-Emulsion huile dans eau1-Oil in water emulsion
Phase huileuse : a Montanov 68 (Cetearyl Alcohol and Cetearyl Glucoside) 5.00 % a Huile de Jojoba 5.00 % a Huile de Vaseline 5.00 % a Isopropyl Palmitate 7.00 %Oily phase: a Montanov 68 (Cetearyl Alcohol and Cetearyl Glucoside) 5.00% Jojoba Oil 5.00% Vaseline Oil 5.00% Isopropyl Palmitate 7.00%
Phase aqueuse : a Glycérine 5.00 % a Allantoïne 0.10 % a Xylanes de l'exemple 1 5.00 % a Sepigel 305 (Polyacrylamide and Cl 3-14 Isoparaffin and Laureth-7) 0.30 % a Conservateur 0.50 % a Parfum 0.50 % a Eau qsp 100 %Aqueous phase: a Glycerin 5.00% a Allantoin 0.10% a Xylans from Example 1 5.00% a Sepigel 305 (Polyacrylamide and Cl 3-14 Isoparaffin and Laureth-7) 0.30% a Preservative 0.50% a Perfume 0.50% a Water qs 100 %
2- Gel2- Gel
a Carbopol Ultrez l0 (sol. à 2% ) 25.00 % a Triéthanolamine 0.50 % a Xylanes de l'exemple 1 1.0 % a Conservateur 0.20 % a EDTA (séquestrant) 0.10 % a Parfum 0.50 % a Eau qsp 100 %a Carbopol Ultrez l0 (2% sol.) 25.00% a Triethanolamine 0.50% a Xylans of example 1 1.0% a Preservative 0.20% a EDTA (sequestering) 0.10% a Perfume 0.50% a Water qs 100%
3- Lotion3- Lotion
a Mono Propylène Glycol 1.00 % a Allantoïne 0.30 % a Glycérine 1.00 % a Cetiol HE (PEG-7 Glyceryl Cocoate) 1.00 % a Xylanes de l'exemple 1 0.1 % a Conservateur 0.20 % a Parfum 0.50 % a Eau qsp 100 % a Mono Propylene Glycol 1.00% a Allantoin 0.30% a Glycerin 1.00% a Cetiol HE (PEG-7 Glyceryl Cocoate) 1.00% a Xylans from Example 1 0.1% a Preservative 0.20% a Perfume 0.50% a Water qs 100%

Claims

REVENDICATIONS
1. Utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés à augmenter l'hydratation et la régénération de la peau et des cheveux.1. Use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to increase the hydration and the regeneration of the skin and the hair.
2. Utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés à traiter de manière curative et/ou préventive les manifestations cutanées du vieillissement (d'origine physiologique et solaire).2. Use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracted from Palmaria; the xylans or the composition being intended to treat curatively and / or preventively the cutaneous manifestations of aging (of physiological and solar origin).
3. Utilisation dans une composition ou pour la préparation d'une telle composition, d'une quantité efficace de xylanes hydrosolubles purifiés, extraits de Palmaria ; les xylanes ou la composition étant destinés à nourrir la peau et les cheveux.3. Use in a composition or for the preparation of such a composition, of an effective amount of purified water-soluble xylans, extracts of Palmaria; the xylans or the composition being intended to nourish the skin and the hair.
4. Utilisation selon l'une quelconque des revendications précédentes, caractérisée en ce que les xylanes hydrosolubles purifiés, extraits de Palmaria sont utilisés en une quantité représentant de 0,0001 % à 5 % du poids total de la composition, et préférentiellement en une quantité représentant de 0,002 % à 1 % du poids total de la composition.4. Use according to any one of the preceding claims, characterized in that the purified water-soluble xylans extracted from Palmaria are used in an amount representing from 0.0001% to 5% of the total weight of the composition, and preferably in an amount representing from 0.002% to 1% of the total weight of the composition.
5. Xylanes, tels que définis dans l'une des revendications précédentes, caractérisés en ce qu'ils sont utilisés sous forme de poudre ou en solution dans un solvant adapté à la cosmétique.5. Xylanes, as defined in one of the preceding claims, characterized in that they are used in the form of powder or in solution in a solvent suitable for cosmetics.
6. Procédé cosmétique pour traiter les manifestations du vieillissement, consistant à appliquer, sur la peau ou les cheveux, la composition selon l'une quelconque des revendications précédentes. Procédé cosmétique pour l'hydratation et la régénération cellulaire, consistant à appliquer, sur la peau ou les cheveux, la composition selon l'une quelconque des revendications précédentes. 6. Cosmetic method for treating the manifestations of aging, consisting in applying, to the skin or the hair, the composition according to any one of the preceding claims. Cosmetic process for hydration and cell regeneration, consisting in applying, to the skin or the hair, the composition according to any one of the preceding claims.
PCT/FR2002/002048 2001-06-27 2002-06-14 Use of purified, water-soluble xylans extracted from palmaria WO2003002085A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108464 2001-06-27
FR0108464A FR2826575B1 (en) 2001-06-27 2001-06-27 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING XYLANES EXTRACTED FROM PALMARIA, USE OF SUCH A COMPOSITION

Publications (1)

Publication Number Publication Date
WO2003002085A1 true WO2003002085A1 (en) 2003-01-09

Family

ID=8864823

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/002048 WO2003002085A1 (en) 2001-06-27 2002-06-14 Use of purified, water-soluble xylans extracted from palmaria

Country Status (2)

Country Link
FR (1) FR2826575B1 (en)
WO (1) WO2003002085A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100009931A1 (en) * 2006-05-05 2010-01-14 L'oreal Association of a tensor agent or device and a saccharide compound
CN103550119A (en) * 2013-10-28 2014-02-05 嘉兴市蝶柔化妆品有限公司 Whitening cream and production method thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2911278B1 (en) * 2007-01-12 2009-05-01 Limousine D Applic Biolog Dite PROCESS FOR OBTAINING DEPIGMENTING COSMETIC ACTIVE INGREDIENT, ACTIVE INGREDIENT OBTAINED AND COMPOSITIONS INCLUDING THE SAME
FR3042974B1 (en) 2015-11-04 2017-12-08 Isp Investments Inc SYNERGISTIC EXTRACT OF PALMARIA PALMATA AND JASMIN, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655268A1 (en) * 1989-12-06 1991-06-07 Secma USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS.
JPH0741419A (en) * 1993-07-28 1995-02-10 Pola Chem Ind Inc Wrinkle-improving agent and anti-aging cosmetic
WO2000059524A1 (en) * 1999-04-01 2000-10-12 Henderson Morley Research And Development Limited Antiviral composition
JP2001172130A (en) * 1999-12-20 2001-06-26 Lion Corp Composition for hair

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655268A1 (en) * 1989-12-06 1991-06-07 Secma USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS.
JPH0741419A (en) * 1993-07-28 1995-02-10 Pola Chem Ind Inc Wrinkle-improving agent and anti-aging cosmetic
WO2000059524A1 (en) * 1999-04-01 2000-10-12 Henderson Morley Research And Development Limited Antiviral composition
JP2001172130A (en) * 1999-12-20 2001-06-26 Lion Corp Composition for hair

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ARS, HELENE ET AL: "Algae: sources of bio-natural active substances", XP002198875, retrieved from STN Database accession no. 126:320879 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; NAGASHIMA, MASATO ET AL: "Application of sea weed extract to cosmetic products", XP002198874, retrieved from STN Database accession no. 127:350989 *
DATABASE WPI Section Ch Week 200153, Derwent World Patents Index; Class A96, AN 2001-485301, XP002198876 *
FRAGRANCE J. (1997), 25(10), 49-55 *
JEREZ J R ET AL: "Chemical modifications of the xylan from Palmaria decipiens", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 32, no. 2, 1 February 1997 (1997-02-01), pages 155 - 159, XP004063807, ISSN: 0144-8617 *
MORGAN K C ET AL: "REVIEW OF CHEMICAL CONSTITUENTS OF THE RED ALGA PALMARIA PALMATA (DULSE)", ECONOMIC BOTANY, NEW YORK BOTANICAL GARDEN, BRONX, NY, US, vol. 34, no. 1, 1980, pages 27 - 50, XP000990733, ISSN: 0013-0001 *
PARFUMS, COSMET., ACTUAL. (1997), 134, 55-58 *
PATENT ABSTRACTS OF JAPAN vol. 1995, no. 05 30 June 1995 (1995-06-30) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100009931A1 (en) * 2006-05-05 2010-01-14 L'oreal Association of a tensor agent or device and a saccharide compound
CN103550119A (en) * 2013-10-28 2014-02-05 嘉兴市蝶柔化妆品有限公司 Whitening cream and production method thereof
CN103550119B (en) * 2013-10-28 2015-07-01 嘉兴市蝶柔化妆品有限公司 Whitening cream and production method thereof

Also Published As

Publication number Publication date
FR2826575A1 (en) 2003-01-03
FR2826575B1 (en) 2007-01-12

Similar Documents

Publication Publication Date Title
EP1638991B1 (en) Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing
EP2515840B1 (en) Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
EP1776082A1 (en) Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition
EP1406589B1 (en) Cosmetic or dermatological use of peptides for promoting adhesion between skin cells
WO2000040611A1 (en) Slimming cosmetic compositions
FR2751537A1 (en) USE OF HONEY AS A KERATOLYTIC AGENT, IN PARTICULAR FOR IMPROVING SKIN DYE SKIN AND TREATING WRINKLES
FR2718639A1 (en) Cosmetic and / or dermatological composition containing a tri (alpha-hydroxyacylate) of glycerol as the sole precursor of glycerol.
WO2001043701A2 (en) Cosmetic or dermopharmaceutical compositions containing the n-palmytoyl-gly-hys-lys tripeptide
FR2837098A1 (en) Cosmetic or pharmaceutical composition, useful for, e.g. combating skin aging and accelerating cicatrization, comprises laminin mimetic pentadecapeptide having cellular adhesion promoting action
EP0756866B1 (en) Use of benzoic acid derivatives for stimulating the renewal of the epidermis and for treating the skin
FR2841781A1 (en) Cosmetic or dermatological composition, e.g. for promoting wound healing and skin regeneration, comprises a peptide including a Leu-Asp-Ala-Pro sequence
EP1406651A2 (en) Cosmetic or dermatological use of peptides for promoting adhesion between skin cells
FR2848844A1 (en) Use of alkyl ether of hydroxystilbene for preparation of cosmetic composition to treat disorders associated with oligoseborrhoeic dry skin e.g. dermatitis
EP1375509A1 (en) Use of a sapogenin, or a natural extract containing the same, for the treatment of oligoseborrheic dry skin
FR2850579A1 (en) Use of di-esters or mono-esters of cinnamic acid and derivatives of vitamin C as donors of nitric oxide in the treatment of skin, mucous membranes and scalp
WO2003002085A1 (en) Use of purified, water-soluble xylans extracted from palmaria
FR2880278A1 (en) Use of oil or proteins extracted from Plukenetia volubilis seed as an active ingredient in the preparation of cosmetic composition or dermatological product e.g. as skin and hair care product
CA2233219C (en) Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration
EP1413291A1 (en) Use of 5-Cholesten-3 beta,25-diol-7-one for the treatment of dry skin or scalp
FR2850578A1 (en) Use of N-benzyl or N-pyridylmethyl iminodiacetic acid derivatives as NO synthesis stimulant for treatment of conditions affecting keratinaceous and mucosal tissue
FR3007652A1 (en) COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE
FR2827171A1 (en) Use of an enzymatic hydrolysate of salmon eggs for preventing or treating the effects of aging caused by physiology or sunlight
FR2826576A1 (en) Topical compositions containing an extract of Kluyveromyces species yeasts, having an anti-aging effect
EP1366743B1 (en) Use of a derivative of 7-oxydated DHEA for treating dry skin
EP1414404B1 (en) Use of date stone extract for treating the signs of aging skin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN CO DZ ID IL IN IS JP KP KR MA MX NO NZ PL RO SG UA US UZ ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG US

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP